Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Minerva Neurosciences, Inc (NERV) Debt to Capital Ratio data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$1.44M |
|
-- |
|
-- |
|
$21.85M |
|
$-21.85M |
|
$23.29M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$-21.85M |
|
$-21.83M |
|
7.57M |
|
7.57M |
|
$0.19 |
|
$0.19 |
|
| Balance Sheet Financials | |
$22.27M |
|
$0.01M |
|
$14.87M |
|
$37.14M |
|
$2.84M |
|
-- |
|
$60.00M |
|
$62.84M |
|
$-25.69M |
|
$-40.56M |
|
$-25.69M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-19.55M |
|
-- |
|
-- |
|
$41.01M |
|
$21.46M |
|
$-19.55M |
|
$1.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.60% |
|
-3.55% |
|
3.87% |
|
-5.60% |
|
$-3.67 |
|
$-2.58 |
|
$-2.58 |
|